Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Forkhead box protein O (FOXO) transcription factors, with DAF-16 as the C. elegans ortholog, are evolutionarily conserved regulators of gene expression that govern stress resistance, metabolism, and longevity[1][2][3][5]. In C. elegans, DAF-16 is the sole FOXO ortholog and the principal downstream effector of the insulin/IGF signaling pathway. When conditions such as food deprivation, heat, or oxidative stress occur, or when insulin/IGF signaling is low, DAF-16 translocates into the nucleus and activates (or represses) specific downstream genes that promote survival, stress resistance, and extended lifespan[1][2][3][4][5]. DAF-16/FOXO activity is regulated by phosphorylation (primarily by AKT), which retains it in the cytoplasm under normal conditions, and by interactions with cofactors such as 14-3-3 proteins, SMK-1/SMEK-1, and HLH-30/TFEB, which modulate its transcriptional output to different cellular threats and developmental cues[2][3][5]. In mammals, the FOXO family comprises multiple paralogs (FOXO1, 3, 4, and 6), which participate in similar pathways affecting cell survival, metabolism, and tumor suppression[2][5]. DAF-16/FOXO represents a central node connecting environmental, hormonal, and developmental signals to gene expression programs ensuring organismal adaptation and longevity[1][2][3][5].
Activation or inhibition of the insulin/IGF signaling pathway alters DAF-16/FOXO nuclear translocation and transcriptional activity[1][2][3][5]; Post-translational modification (e.g., phosphorylation by AKT, MST1, or sequestration by 14-3-3 proteins) regulates its cellular localization and activity[1][2][3][4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Forkhead box protein O (FOXO) transcription factor (DAF-16 ortholog in *Caenorhabditis elegans*) (DAF-16/FOXO).